Anemia of chronic diseases as an interdisciplinary problem

Abstract

Anemia is believed to be a medico-social problem affecting a great part of population. Anemia of chronic diseases represents a considerable number of these disorders, which is particularly challenging for long-standing inflammatory processes, systemic diseases and neoplasms. Pathogenesis of this type of anemia is characterized by complex and miltifactorial nature. Pathogenesis is based on disturbance of erythropoietin synthesis and erythropoiesis precursor cells sensitivity, hyperproduction of factors inhibiting erythropoiesis (tumor necrosis factor, interleukins), disturbance of iron metabolism and other hemopoiesis co-factors. Anemia aggravates associated underlying disease course. Quality of life and overall survival deteriorate. Treatment efficacy for anemia influences the time of patient recovery, as well as success of treatment of other diseases. Iron deficiency and erythropoiesis disturbance, similar to hypoferric anemia, are of great importance. However, iron therapy may aggravate patient’s condition, hence differential diagnosis of this anemia type and true iron deficiency anemia has a great practical value. In the treatment of anemia in the presence of chronic diseases and anemia in the presence of hematologic diseases, the goal of the treatment is generally limited by the improvement of patient’s quality of life, target value of hemoglobin for transfusion or erythropoiesis stimulating therapy remaining the subject for discussion. Hemoglobin target determination in individuals with cardiac and pulmonary insufficiency who are on chemotherapy, is critically important, because it is this category of patients that does not demonstrate generally accepted target values of hemoglobin, the level of which is not always indicative of hypoxia absence. The review presents current data on diagnosis, treatment of chronic disease anemia (1 figure, 2 tables, bibliography: 12 refs).

Keywords

anemia / chronic disease anemia / erythropoietin / ferritin / ferroportin / hepcidin / iron metabolism

References

[1] Weiss G, Goodnough LT. Anemia of Chronic Disease. New Eng J Med. 2005;352(10):1011–1023.

[2] Weiss G., Goodnough L.T. Anemia of Chronic Disease // New. Eng. J. Med. 2005. Vol. 352, No. 10. P. 1011–1023.

[3] Sakhin VT, Grigoriev MA, Kryukov EV, et al. Pathogenetic features of anemia of chronic diseases in patients with malignant neoplasms and rheumatic pathology. Oncohematology. 2020;15(4):82–90. (In Russ.) DOI: 10.17650/1818-8346-2020-15-4-82-90

[4] Сахин В.Т., Григорьев М.А., Крюков Е.В., и др. Патогенетические особенности развития анемии хронических заболеваний у больных со злокачественными новообразованиями и ревматической патологией // Онкогематология. 2020. № 15 (4). С. 82–90. DOI: 10.17650/1818-8346-2020-15-4-82-90

[5] Sakhin VТ, Madzhanova ЕR, Kryukov EV, Kazakov SP, Rukavitsyn OA. Anemia of chronic disease: features of pathogenesis and possible therapeutic correction (literature review and results of own research). Oncohematology. 2018;13(1):45–53. (In Russ.) DOI: 10.17650/1818-8346-2018-13-1-45-53

[6] Сахин В.Т., Маджанова Е.Р., Крюков Е.В., Казаков С.П., Рукавицын О.А. Анемия хронических заболеваний: особенности патогенеза и возможности терапевтической коррекции (обзор литературы и результаты собственных исследований) // Онкогематология. 2018. Т. 13, № 1. С. 45–53. DOI: 10.17650/1818-8346-2018-13-1-45-53

[7] Panahova DZ. Anaemia of chronic diseases. The bulletin of hematology. 2017;13(1):33–39. (In Russ.)

[8] Панахова Д.З. Анемия хронических заболеваний // Вестник гематологии. 2017. Т. 13, № 1. С. 33–39.

[9] Sakhin VT, Kryukov EV, Grigor’yev MA, et al. Features of the secretion of interleukin-6, interleukin-1β, interferon-γ and their influence on the development of anemia of chronic diseases in patients with rheumatic pathology. Medical Bulletin of the Main Military Clinical Hospital named after N.N. Burdenko. 2021;4(2):26–33. (In Russ.)

[10] Сахин В.Т., Крюков Е.В., Григорьев М.А., и др. Особенности секреции интерлейкина-6, интерлейкина-1β, интерферона-γ и их влияние на развитие анемии хронических заболеваний у пациентов с ревматической патологией // Медицинский вестник ГВКГ им. Н.Н. Бурденко. 2021. Т. 4, № 2. С. 26–33.

[11] Sakhin VT. Anemia of Chronic Disease. Kryukov EV, ed. Moscow; 2020. 160 p. (In Russ.)

[12] Сахин В.Т. Анемия хронических заболеваний / под общ. ред. Е.В. Крюкова. М.: ГЭОТАР-Медиа, 2020. 160 с.

[13] Ganz T, Nemeth E. Hepsidin and iron homeostasis. Biochim Biophys Acta. 2012;1823(9):1434–1443.

[14] Ganz T., Nemeth E. Hepsidin and iron homeostasis // Biochim. Biophys. Acta. 2012. Vol. 1823, No. 9. P. 1434–1443.

[15] Skikne B, Punnonen K, Caldron P, et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: A prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol. 2011;86(11):923–927.

[16] Skikne B., Punnonen K., Caldron P., et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: A prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index // Am. J. Hematol. 2011. Vol. 86, No. 11. P. 923–927.

[17] Romanenko NA. Anemia in patients with oncohematological diseases: features of pathogenesis, methods of correction, quality of life. D.Sc. (Medicine) thesis. 14.01.21. Saint Petersburg; 2015. 299 p. (In Russ.)

[18] Романенко Н.А. Анемия у больных онкогематологическими заболеваниями: особенности патогенеза, методы коррекции, качество жизни. Дис. … докт. мед. наук: 14.01.21. СПб., 2015. 299 с.

[19] Rumyantsev AG, Maschan AA, Demikhov VG, et al. Anemia in malignant neoplasms. Clinical guidelines. Мoscow; 2020. 37 p. (In Russ.) Available at: www.https://cr.minzdrav.gov.ru/recomend/624_1 (accessed 10.05.2021).

[20] Румянцев А.Г., Масчан А.А., Демихов В.Г., и др. Анемия при злокачественных новообразованиях. Клинические рекомендации. М., 2020. 37 с. Доступен по: https://cr.minzdrav.gov.ru/recomend/624 (дата обращения 14.09.2021).

[21] Kovalev AV, Bondarchuk SV. Quality of life in patients with anemia, ways of treatment. Russian Military Medical Academy Reports. 2019;38(S1–3):117–121. (In Russ.)

[22] Ковалев А.В., Бондарчук С.В. Качество жизни пациентов с анемией, пути коррекции // Известия Российской Военно-медицинской академии. 2019. Т. 38, No. S1–3. С. 117–121.

[23] Sakhin VT, Kryukov EV, Rukavitsуn OA. Anemia of chronic diseases – features of pathogenesis and an attempt at classification. Pacific Medical Journal. 2019;1(75):33–37. DOI: 10.17238/PmJ1609-1175.2019.1.33-37

[24] Сахин В.Т., Крюков Е.В., Рукавицын О.А. Анемия хронических заболеваний — особенности патогенеза и попытка классификации // Тихоокеанский медицинский журнал. 2019. № 1 (75). С. 33–37. DOI: 10.17238/PmJ1609-1175.2019.1.33-37

RIGHTS & PERMISSIONS

Bondarchuk S.V., Golovko K.P., Ovchinnikov D.V.